Global Super Generic Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Super Generic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Super Generic Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Super Generic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Super Generic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Super Generic Drugs total production and demand, 2018-2029, (K Units)
Global Super Generic Drugs total production value, 2018-2029, (USD Million)
Global Super Generic Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Super Generic Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Super Generic Drugs domestic production, consumption, key domestic manufacturers and share
Global Super Generic Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Super Generic Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Super Generic Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Super Generic Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Super Generic Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Super Generic Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Super Generic Drugs Market, Segmentation by Type
    Traditional Generic Drugs
    Biosimilars

Global Super Generic Drugs Market, Segmentation by Application
    CNS
    Cardiovascular
    Genitourinary/Hormonal Drugs
    Respiratory
    Rheumatology
    Diabetes
    Oncology
    Others

Companies Profiled:
    Teva
    Novartis - Sandoz
    Mylan
    Sun Pharmaceutical
    Aspen
    Fresenius Kabi
    Pfizer (Hospira)
    Sanofi
    Aurobindo
    Lupin
    Dr. Reddy's
    Apotex
    Cipla
    ENDO (Par Pharmaceutical)
    Stada Arzneimittel
    Krka Group
    Nichi-Iko Pharmaceutical
    Valeant
    Zydus Cadila
    Hikma

Key Questions Answered
1. How big is the global Super Generic Drugs market?
2. What is the demand of the global Super Generic Drugs market?
3. What is the year over year growth of the global Super Generic Drugs market?
4. What is the production and production value of the global Super Generic Drugs market?
5. Who are the key producers in the global Super Generic Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Super Generic Drugs Introduction
    1.2 World Super Generic Drugs Supply & Forecast
        1.2.1 World Super Generic Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Super Generic Drugs Production (2018-2029)
        1.2.3 World Super Generic Drugs Pricing Trends (2018-2029)
    1.3 World Super Generic Drugs Production by Region (Based on Production Site)
        1.3.1 World Super Generic Drugs Production Value by Region (2018-2029)
        1.3.2 World Super Generic Drugs Production by Region (2018-2029)
        1.3.3 World Super Generic Drugs Average Price by Region (2018-2029)
        1.3.4 North America Super Generic Drugs Production (2018-2029)
        1.3.5 Europe Super Generic Drugs Production (2018-2029)
        1.3.6 China Super Generic Drugs Production (2018-2029)
        1.3.7 Japan Super Generic Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Super Generic Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Super Generic Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Super Generic Drugs Demand (2018-2029)
    2.2 World Super Generic Drugs Consumption by Region
        2.2.1 World Super Generic Drugs Consumption by Region (2018-2023)
        2.2.2 World Super Generic Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Super Generic Drugs Consumption (2018-2029)
    2.4 China Super Generic Drugs Consumption (2018-2029)
    2.5 Europe Super Generic Drugs Consumption (2018-2029)
    2.6 Japan Super Generic Drugs Consumption (2018-2029)
    2.7 South Korea Super Generic Drugs Consumption (2018-2029)
    2.8 ASEAN Super Generic Drugs Consumption (2018-2029)
    2.9 India Super Generic Drugs Consumption (2018-2029)

3 World Super Generic Drugs Manufacturers Competitive Analysis
    3.1 World Super Generic Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Super Generic Drugs Production by Manufacturer (2018-2023)
    3.3 World Super Generic Drugs Average Price by Manufacturer (2018-2023)
    3.4 Super Generic Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Super Generic Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Super Generic Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Super Generic Drugs in 2022
    3.6 Super Generic Drugs Market: Overall Company Footprint Analysis
        3.6.1 Super Generic Drugs Market: Region Footprint
        3.6.2 Super Generic Drugs Market: Company Product Type Footprint
        3.6.3 Super Generic Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Super Generic Drugs Production Value Comparison
        4.1.1 United States VS China: Super Generic Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Super Generic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Super Generic Drugs Production Comparison
        4.2.1 United States VS China: Super Generic Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Super Generic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Super Generic Drugs Consumption Comparison
        4.3.1 United States VS China: Super Generic Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Super Generic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Super Generic Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Super Generic Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Super Generic Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Super Generic Drugs Production (2018-2023)
    4.5 China Based Super Generic Drugs Manufacturers and Market Share
        4.5.1 China Based Super Generic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Super Generic Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Super Generic Drugs Production (2018-2023)
    4.6 Rest of World Based Super Generic Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Super Generic Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Super Generic Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Super Generic Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Super Generic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Traditional Generic Drugs
        5.2.2 Biosimilars
    5.3 Market Segment by Type
        5.3.1 World Super Generic Drugs Production by Type (2018-2029)
        5.3.2 World Super Generic Drugs Production Value by Type (2018-2029)
        5.3.3 World Super Generic Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Super Generic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 CNS
        6.2.2 Cardiovascular
        6.2.3 Genitourinary/Hormonal Drugs
        6.2.4 Respiratory
        6.2.5 Rheumatology
        6.2.6 Diabetes
        6.2.7 Oncology
        6.2.8 Others
    6.3 Market Segment by Application
        6.3.1 World Super Generic Drugs Production by Application (2018-2029)
        6.3.2 World Super Generic Drugs Production Value by Application (2018-2029)
        6.3.3 World Super Generic Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Teva
        7.1.1 Teva Details
        7.1.2 Teva Major Business
        7.1.3 Teva Super Generic Drugs Product and Services
        7.1.4 Teva Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Teva Recent Developments/Updates
        7.1.6 Teva Competitive Strengths & Weaknesses
    7.2 Novartis - Sandoz
        7.2.1 Novartis - Sandoz Details
        7.2.2 Novartis - Sandoz Major Business
        7.2.3 Novartis - Sandoz Super Generic Drugs Product and Services
        7.2.4 Novartis - Sandoz Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis - Sandoz Recent Developments/Updates
        7.2.6 Novartis - Sandoz Competitive Strengths & Weaknesses
    7.3 Mylan
        7.3.1 Mylan Details
        7.3.2 Mylan Major Business
        7.3.3 Mylan Super Generic Drugs Product and Services
        7.3.4 Mylan Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Mylan Recent Developments/Updates
        7.3.6 Mylan Competitive Strengths & Weaknesses
    7.4 Sun Pharmaceutical
        7.4.1 Sun Pharmaceutical Details
        7.4.2 Sun Pharmaceutical Major Business
        7.4.3 Sun Pharmaceutical Super Generic Drugs Product and Services
        7.4.4 Sun Pharmaceutical Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Sun Pharmaceutical Recent Developments/Updates
        7.4.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
    7.5 Aspen
        7.5.1 Aspen Details
        7.5.2 Aspen Major Business
        7.5.3 Aspen Super Generic Drugs Product and Services
        7.5.4 Aspen Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Aspen Recent Developments/Updates
        7.5.6 Aspen Competitive Strengths & Weaknesses
    7.6 Fresenius Kabi
        7.6.1 Fresenius Kabi Details
        7.6.2 Fresenius Kabi Major Business
        7.6.3 Fresenius Kabi Super Generic Drugs Product and Services
        7.6.4 Fresenius Kabi Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Fresenius Kabi Recent Developments/Updates
        7.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
    7.7 Pfizer (Hospira)
        7.7.1 Pfizer (Hospira) Details
        7.7.2 Pfizer (Hospira) Major Business
        7.7.3 Pfizer (Hospira) Super Generic Drugs Product and Services
        7.7.4 Pfizer (Hospira) Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Pfizer (Hospira) Recent Developments/Updates
        7.7.6 Pfizer (Hospira) Competitive Strengths & Weaknesses
    7.8 Sanofi
        7.8.1 Sanofi Details
        7.8.2 Sanofi Major Business
        7.8.3 Sanofi Super Generic Drugs Product and Services
        7.8.4 Sanofi Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Sanofi Recent Developments/Updates
        7.8.6 Sanofi Competitive Strengths & Weaknesses
    7.9 Aurobindo
        7.9.1 Aurobindo Details
        7.9.2 Aurobindo Major Business
        7.9.3 Aurobindo Super Generic Drugs Product and Services
        7.9.4 Aurobindo Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Aurobindo Recent Developments/Updates
        7.9.6 Aurobindo Competitive Strengths & Weaknesses
    7.10 Lupin
        7.10.1 Lupin Details
        7.10.2 Lupin Major Business
        7.10.3 Lupin Super Generic Drugs Product and Services
        7.10.4 Lupin Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Lupin Recent Developments/Updates
        7.10.6 Lupin Competitive Strengths & Weaknesses
    7.11 Dr. Reddy's
        7.11.1 Dr. Reddy's Details
        7.11.2 Dr. Reddy's Major Business
        7.11.3 Dr. Reddy's Super Generic Drugs Product and Services
        7.11.4 Dr. Reddy's Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Dr. Reddy's Recent Developments/Updates
        7.11.6 Dr. Reddy's Competitive Strengths & Weaknesses
    7.12 Apotex
        7.12.1 Apotex Details
        7.12.2 Apotex Major Business
        7.12.3 Apotex Super Generic Drugs Product and Services
        7.12.4 Apotex Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Apotex Recent Developments/Updates
        7.12.6 Apotex Competitive Strengths & Weaknesses
    7.13 Cipla
        7.13.1 Cipla Details
        7.13.2 Cipla Major Business
        7.13.3 Cipla Super Generic Drugs Product and Services
        7.13.4 Cipla Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Cipla Recent Developments/Updates
        7.13.6 Cipla Competitive Strengths & Weaknesses
    7.14 ENDO (Par Pharmaceutical)
        7.14.1 ENDO (Par Pharmaceutical) Details
        7.14.2 ENDO (Par Pharmaceutical) Major Business
        7.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Product and Services
        7.14.4 ENDO (Par Pharmaceutical) Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 ENDO (Par Pharmaceutical) Recent Developments/Updates
        7.14.6 ENDO (Par Pharmaceutical) Competitive Strengths & Weaknesses
    7.15 Stada Arzneimittel
        7.15.1 Stada Arzneimittel Details
        7.15.2 Stada Arzneimittel Major Business
        7.15.3 Stada Arzneimittel Super Generic Drugs Product and Services
        7.15.4 Stada Arzneimittel Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Stada Arzneimittel Recent Developments/Updates
        7.15.6 Stada Arzneimittel Competitive Strengths & Weaknesses
    7.16 Krka Group
        7.16.1 Krka Group Details
        7.16.2 Krka Group Major Business
        7.16.3 Krka Group Super Generic Drugs Product and Services
        7.16.4 Krka Group Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Krka Group Recent Developments/Updates
        7.16.6 Krka Group Competitive Strengths & Weaknesses
    7.17 Nichi-Iko Pharmaceutical
        7.17.1 Nichi-Iko Pharmaceutical Details
        7.17.2 Nichi-Iko Pharmaceutical Major Business
        7.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Product and Services
        7.17.4 Nichi-Iko Pharmaceutical Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
        7.17.6 Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
    7.18 Valeant
        7.18.1 Valeant Details
        7.18.2 Valeant Major Business
        7.18.3 Valeant Super Generic Drugs Product and Services
        7.18.4 Valeant Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Valeant Recent Developments/Updates
        7.18.6 Valeant Competitive Strengths & Weaknesses
    7.19 Zydus Cadila
        7.19.1 Zydus Cadila Details
        7.19.2 Zydus Cadila Major Business
        7.19.3 Zydus Cadila Super Generic Drugs Product and Services
        7.19.4 Zydus Cadila Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Zydus Cadila Recent Developments/Updates
        7.19.6 Zydus Cadila Competitive Strengths & Weaknesses
    7.20 Hikma
        7.20.1 Hikma Details
        7.20.2 Hikma Major Business
        7.20.3 Hikma Super Generic Drugs Product and Services
        7.20.4 Hikma Super Generic Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Hikma Recent Developments/Updates
        7.20.6 Hikma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Super Generic Drugs Industry Chain
    8.2 Super Generic Drugs Upstream Analysis
        8.2.1 Super Generic Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Super Generic Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Super Generic Drugs Production Mode
    8.6 Super Generic Drugs Procurement Model
    8.7 Super Generic Drugs Industry Sales Model and Sales Channels
        8.7.1 Super Generic Drugs Sales Model
        8.7.2 Super Generic Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Super Generic Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Super Generic Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Super Generic Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Super Generic Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Super Generic Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Super Generic Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Super Generic Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Super Generic Drugs Production Market Share by Region (2018-2023)
    Table 9. World Super Generic Drugs Production Market Share by Region (2024-2029)
    Table 10. World Super Generic Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Super Generic Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Super Generic Drugs Major Market Trends
    Table 13. World Super Generic Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Super Generic Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Super Generic Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Super Generic Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Super Generic Drugs Producers in 2022
    Table 18. World Super Generic Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Super Generic Drugs Producers in 2022
    Table 20. World Super Generic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Super Generic Drugs Company Evaluation Quadrant
    Table 22. World Super Generic Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Super Generic Drugs Production Site of Key Manufacturer
    Table 24. Super Generic Drugs Market: Company Product Type Footprint
    Table 25. Super Generic Drugs Market: Company Product Application Footprint
    Table 26. Super Generic Drugs Competitive Factors
    Table 27. Super Generic Drugs New Entrant and Capacity Expansion Plans
    Table 28. Super Generic Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Super Generic Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Super Generic Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Super Generic Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Super Generic Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Super Generic Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Super Generic Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Super Generic Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Super Generic Drugs Production Market Share (2018-2023)
    Table 37. China Based Super Generic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Super Generic Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Super Generic Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Super Generic Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Super Generic Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Super Generic Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Super Generic Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Super Generic Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Super Generic Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Super Generic Drugs Production Market Share (2018-2023)
    Table 47. World Super Generic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Super Generic Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Super Generic Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Super Generic Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Super Generic Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Super Generic Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Super Generic Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Super Generic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Super Generic Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Super Generic Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Super Generic Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Super Generic Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Super Generic Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Super Generic Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Teva Basic Information, Manufacturing Base and Competitors
    Table 62. Teva Major Business
    Table 63. Teva Super Generic Drugs Product and Services
    Table 64. Teva Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Teva Recent Developments/Updates
    Table 66. Teva Competitive Strengths & Weaknesses
    Table 67. Novartis - Sandoz Basic Information, Manufacturing Base and Competitors
    Table 68. Novartis - Sandoz Major Business
    Table 69. Novartis - Sandoz Super Generic Drugs Product and Services
    Table 70. Novartis - Sandoz Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Novartis - Sandoz Recent Developments/Updates
    Table 72. Novartis - Sandoz Competitive Strengths & Weaknesses
    Table 73. Mylan Basic Information, Manufacturing Base and Competitors
    Table 74. Mylan Major Business
    Table 75. Mylan Super Generic Drugs Product and Services
    Table 76. Mylan Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Mylan Recent Developments/Updates
    Table 78. Mylan Competitive Strengths & Weaknesses
    Table 79. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 80. Sun Pharmaceutical Major Business
    Table 81. Sun Pharmaceutical Super Generic Drugs Product and Services
    Table 82. Sun Pharmaceutical Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Sun Pharmaceutical Recent Developments/Updates
    Table 84. Sun Pharmaceutical Competitive Strengths & Weaknesses
    Table 85. Aspen Basic Information, Manufacturing Base and Competitors
    Table 86. Aspen Major Business
    Table 87. Aspen Super Generic Drugs Product and Services
    Table 88. Aspen Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Aspen Recent Developments/Updates
    Table 90. Aspen Competitive Strengths & Weaknesses
    Table 91. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 92. Fresenius Kabi Major Business
    Table 93. Fresenius Kabi Super Generic Drugs Product and Services
    Table 94. Fresenius Kabi Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Fresenius Kabi Recent Developments/Updates
    Table 96. Fresenius Kabi Competitive Strengths & Weaknesses
    Table 97. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
    Table 98. Pfizer (Hospira) Major Business
    Table 99. Pfizer (Hospira) Super Generic Drugs Product and Services
    Table 100. Pfizer (Hospira) Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Pfizer (Hospira) Recent Developments/Updates
    Table 102. Pfizer (Hospira) Competitive Strengths & Weaknesses
    Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 104. Sanofi Major Business
    Table 105. Sanofi Super Generic Drugs Product and Services
    Table 106. Sanofi Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Sanofi Recent Developments/Updates
    Table 108. Sanofi Competitive Strengths & Weaknesses
    Table 109. Aurobindo Basic Information, Manufacturing Base and Competitors
    Table 110. Aurobindo Major Business
    Table 111. Aurobindo Super Generic Drugs Product and Services
    Table 112. Aurobindo Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Aurobindo Recent Developments/Updates
    Table 114. Aurobindo Competitive Strengths & Weaknesses
    Table 115. Lupin Basic Information, Manufacturing Base and Competitors
    Table 116. Lupin Major Business
    Table 117. Lupin Super Generic Drugs Product and Services
    Table 118. Lupin Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Lupin Recent Developments/Updates
    Table 120. Lupin Competitive Strengths & Weaknesses
    Table 121. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
    Table 122. Dr. Reddy's Major Business
    Table 123. Dr. Reddy's Super Generic Drugs Product and Services
    Table 124. Dr. Reddy's Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Dr. Reddy's Recent Developments/Updates
    Table 126. Dr. Reddy's Competitive Strengths & Weaknesses
    Table 127. Apotex Basic Information, Manufacturing Base and Competitors
    Table 128. Apotex Major Business
    Table 129. Apotex Super Generic Drugs Product and Services
    Table 130. Apotex Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Apotex Recent Developments/Updates
    Table 132. Apotex Competitive Strengths & Weaknesses
    Table 133. Cipla Basic Information, Manufacturing Base and Competitors
    Table 134. Cipla Major Business
    Table 135. Cipla Super Generic Drugs Product and Services
    Table 136. Cipla Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Cipla Recent Developments/Updates
    Table 138. Cipla Competitive Strengths & Weaknesses
    Table 139. ENDO (Par Pharmaceutical) Basic Information, Manufacturing Base and Competitors
    Table 140. ENDO (Par Pharmaceutical) Major Business
    Table 141. ENDO (Par Pharmaceutical) Super Generic Drugs Product and Services
    Table 142. ENDO (Par Pharmaceutical) Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. ENDO (Par Pharmaceutical) Recent Developments/Updates
    Table 144. ENDO (Par Pharmaceutical) Competitive Strengths & Weaknesses
    Table 145. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
    Table 146. Stada Arzneimittel Major Business
    Table 147. Stada Arzneimittel Super Generic Drugs Product and Services
    Table 148. Stada Arzneimittel Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Stada Arzneimittel Recent Developments/Updates
    Table 150. Stada Arzneimittel Competitive Strengths & Weaknesses
    Table 151. Krka Group Basic Information, Manufacturing Base and Competitors
    Table 152. Krka Group Major Business
    Table 153. Krka Group Super Generic Drugs Product and Services
    Table 154. Krka Group Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Krka Group Recent Developments/Updates
    Table 156. Krka Group Competitive Strengths & Weaknesses
    Table 157. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 158. Nichi-Iko Pharmaceutical Major Business
    Table 159. Nichi-Iko Pharmaceutical Super Generic Drugs Product and Services
    Table 160. Nichi-Iko Pharmaceutical Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Nichi-Iko Pharmaceutical Recent Developments/Updates
    Table 162. Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
    Table 163. Valeant Basic Information, Manufacturing Base and Competitors
    Table 164. Valeant Major Business
    Table 165. Valeant Super Generic Drugs Product and Services
    Table 166. Valeant Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Valeant Recent Developments/Updates
    Table 168. Valeant Competitive Strengths & Weaknesses
    Table 169. Zydus Cadila Basic Information, Manufacturing Base and Competitors
    Table 170. Zydus Cadila Major Business
    Table 171. Zydus Cadila Super Generic Drugs Product and Services
    Table 172. Zydus Cadila Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Zydus Cadila Recent Developments/Updates
    Table 174. Hikma Basic Information, Manufacturing Base and Competitors
    Table 175. Hikma Major Business
    Table 176. Hikma Super Generic Drugs Product and Services
    Table 177. Hikma Super Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 178. Global Key Players of Super Generic Drugs Upstream (Raw Materials)
    Table 179. Super Generic Drugs Typical Customers
    Table 180. Super Generic Drugs Typical Distributors
List of Figure
    Figure 1. Super Generic Drugs Picture
    Figure 2. World Super Generic Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Super Generic Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Super Generic Drugs Production (2018-2029) & (K Units)
    Figure 5. World Super Generic Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Super Generic Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Super Generic Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Super Generic Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Super Generic Drugs Production (2018-2029) & (K Units)
    Figure 10. China Super Generic Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Super Generic Drugs Production (2018-2029) & (K Units)
    Figure 12. Super Generic Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Super Generic Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Super Generic Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Super Generic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Super Generic Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Super Generic Drugs Markets in 2022
    Figure 26. United States VS China: Super Generic Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Super Generic Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Super Generic Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Super Generic Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Super Generic Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Super Generic Drugs Production Market Share 2022
    Figure 32. World Super Generic Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Super Generic Drugs Production Value Market Share by Type in 2022
    Figure 34. Traditional Generic Drugs
    Figure 35. Biosimilars
    Figure 36. World Super Generic Drugs Production Market Share by Type (2018-2029)
    Figure 37. World Super Generic Drugs Production Value Market Share by Type (2018-2029)
    Figure 38. World Super Generic Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Super Generic Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Super Generic Drugs Production Value Market Share by Application in 2022
    Figure 41. CNS
    Figure 42. Cardiovascular
    Figure 43. Genitourinary/Hormonal Drugs
    Figure 44. Respiratory
    Figure 45. Rheumatology
    Figure 46. Diabetes
    Figure 47. Oncology
    Figure 48. Others
    Figure 49. World Super Generic Drugs Production Market Share by Application (2018-2029)
    Figure 50. World Super Generic Drugs Production Value Market Share by Application (2018-2029)
    Figure 51. World Super Generic Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 52. Super Generic Drugs Industry Chain
    Figure 53. Super Generic Drugs Procurement Model
    Figure 54. Super Generic Drugs Sales Model
    Figure 55. Super Generic Drugs Sales Channels, Direct Sales, and Distribution
    Figure 56. Methodology
    Figure 57. Research Process and Data Source